Medication info

Quran Injection 50 mg (Ranitidine Hydrochloride)

Prescription medicationOral · Intramuscular injection · Intravenous injectionApproval withdrawn
Ingredient · strength
Ranitidine Hydrochloride›56mg / 1 ampoule
Manufacturer / importer
Ildong Pharmaceutical Co., Ltd.
Appearance
A clear liquid that is colorless to light yellow in color, packaged in brown ampoules.
Packaging
50 ampoules/box [(2 mL/ampoule)]
Approval status
Approval withdrawn

MFDS item code 198600224 · Notified 1986.04.04

This product's status changed to Approval withdrawn on 2024.07.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of upper gastrointestinal bleeding and acid-related disorders; prevention of Mendelson syndrome
Who uses it
Adults · Children
Adult dosage
Adults: Administer 50mg of ranitidine intravenously or intramuscularly 3-4 times daily. For intravenous injection, dilute 50mg of this drug in 20ml of Normal Saline Injection or Dextrose Injection and inject slowly over at least 2 minutes, or mix with an infusion solution and administer by intravenous drip infusion over 2 hours at a rate of 25mg/hr. For upper gastrointestinal bleeding, an effect is generally seen within 1 week. Switch to oral administration when oral dosing becomes possible. For preanesthetic medication (prevention of Mendelson's syndrome), administer 50mg intramuscularly or slowly by intravenous injection over 1 minute, 45-60 minutes before induction of anesthesia. Patients with renal impairment: In patients with severe renal impairment and creatinine clearance of 50ml/min or less, reduce the dose to 25 mg per dose, or extend the dosing interval and administer 50mg every 18-24 hours. Depending on the patient's condition, 50mg may be administered every 12 hours. Hemodialysis reduces the blood concentration of the drug; therefore, adjust the dosing schedule after hemodialysis. Adjust the dose as appropriate according to age and symptoms.
Children's dosage
Children: Clinical studies in children have not been established.

Ingredients

Manufacturer
Ildong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of upper gastrointestinal bleeding and acid-related disorders; prevention of Mendelson syndrome

  • Gastric ulcer
  • duodenal ulcer
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcers
  • upper gastrointestinal bleeding
  • peptic ulcers
  • acute stress ulcers
  • acute gastric mucosal lesions.
View approved original text

This medication is effective in treating gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also used to prevent Mendelson's syndrome during preoperative anesthesia and helps treat ulcers that may arise post-surgery. Additionally, it is used to treat upper gastrointestinal bleeding due to acute stress ulcers and acute gastric mucosal lesions. This drug is effective in improving various gastrointestinal conditions.

Dosage and Administration

Adult dosage

Adults: Administer 50mg of ranitidine intravenously or intramuscularly 3-4 times daily. For intravenous injection, dilute 50mg of this drug in 20ml of Normal Saline Injection or Dextrose Injection and inject slowly over at least 2 minutes, or mix with an infusion solution and administer by intravenous drip infusion over 2 hours at a rate of 25mg/hr. For upper gastrointestinal bleeding, an effect is generally seen within 1 week. Switch to oral administration when oral dosing becomes possible. For preanesthetic medication (prevention of Mendelson's syndrome), administer 50mg intramuscularly or slowly by intravenous injection over 1 minute, 45-60 minutes before induction of anesthesia. Patients with renal impairment: In patients with severe renal impairment and creatinine clearance of 50ml/min or less, reduce the dose to 25 mg per dose, or extend the dosing interval and administer 50mg every 18-24 hours. Depending on the patient's condition, 50mg may be administered every 12 hours. Hemodialysis reduces the blood concentration of the drug; therefore, adjust the dosing schedule after hemodialysis. Adjust the dose as appropriate according to age and symptoms.

Children's dosage

Children: Clinical studies in children have not been established.

Precautions

This medication should be opened carefully as it comes in glass ampoules to prevent glass fragments from mixing in, especially with children and the elderly. It should not be used in patients with a history of allergic reactions to this drug or its components. In patients with impaired kidney function, the drug may remain in the body for an extended period, thus the dosage should be reduced or the dosing interval extended. Patients with poor liver function, a history of drug allergies, the elderly, and those with acute porphyria should use this medication with caution. While using this medication, severe allergic reactions, blood disorders, liver dysfunction, irregular heartbeats, gastrointestinal issues, or neurological symptoms may occur; if any unusual symptoms arise, discontinue use and seek medical attention immediately. It is vital to monitor the patient's condition regularly and perform blood tests, liver function tests, and kidney function tests during treatment. Elderly patients or those with chronic diseases may be at increased risk of pneumonia, so caution is warranted. If this medication is to be injected intravenously for more than five days, there is a possibility of elevated liver enzyme levels, so daily liver function tests are recommended. If oral administration is possible, it is advised to switch to oral medication as soon as feasible. This medication may interact with other drugs, so it is essential to inform the doctor or pharmacist if other medications are being taken, especially when used with anticoagulants, as there may be an increased risk of bleeding. Women who are pregnant or may become pregnant, as well as nursing women, should carefully weigh the risks and benefits of using this medication. The safety of this drug in children has not been adequately established, thus caution is advised. In cases of overdose, gastric emptying treatment should be received along with appropriate symptomatic treatment, and blood dialysis may be performed if necessary. When administrating the injection, pain or hardness at the injection site may occur, and there is a risk of irregular heartbeats; therefore, the injection should be administered slowly. This medication may mask the symptoms of stomach cancer, so patients with gastric ulcers or newly developed dyspepsia who are middle-aged or older should be checked for malignancy before use. Long-term use may affect eye health, so regular ophthalmological examinations are necessary.

Side effects

  • Anaphylactic shock
  • urticaria
  • angioedema
  • rash
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • vascular edema
  • granulocytopenia
Show 61 more
  • increased serum creatinine levels
  • leukopenia
  • thrombocytopenia
  • bone marrow suppression
  • aplastic anemia
  • hypoplastic anemia
  • agranulocytosis
  • pancytopenia
  • acquired immune hemolytic anemia
  • eosinophilia
  • generalized malaise
  • fatigue
  • subcutaneous and mucosal bleeding
  • liver dysfunction
  • jaundice
  • hepatitis
  • bradycardia
  • atrioventricular block
  • tachycardia
  • vasculitis
  • cardiac asystole
  • constipation
  • nausea
  • vomiting
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • diarrhea
  • acute pancreatitis
  • dizziness
  • drowsiness
  • seizures
  • headache
  • heaviness in the head
  • insomnia
  • agitation
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • altered consciousness
  • hepatic myoclonus
  • gynecomastia
  • excessive lactation
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • stomatitis
  • pruritus
  • Stevens-Johnson syndrome
  • Lyell's syndrome
  • acute interstitial nephritis
  • pain at the muscle injection site
  • induration at the muscle injection site

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a cool place below 30 degrees Celsius, protected from light in a sealed container, to maintain its efficacy for a longer period.

Appearance and packaging

Appearance

A clear liquid that is colorless to light yellow in color, packaged in brown ampoules.

Package unit

50 ampoules/box [(2 mL/ampoule)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.